NasdaqCM - Delayed Quote USD
Zentek Ltd. (ZTEK)
At close: October 25 at 4:00 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
35.3050
29.8160
72.8550
339.6660
--
--
Cost of Revenue
356.4480
331.0800
853.3360
376.7870
126.7990
--
Gross Profit
-321.1430
-301.2640
-780.4810
-37.1210
-126.7990
--
Operating Expense
10,940.5270
11,677.2540
13,872.4640
11,947.8540
3,978.4470
--
Operating Income
-11,261.6700
-11,978.5180
-14,652.9450
-11,984.9750
-3,978.4470
--
Net Non Operating Interest Income Expense
189.1050
293.4120
384.8000
-46.5390
-2.3530
--
Other Income Expense
-128.3580
-118.6680
-146.1210
-19,662.5340
112.1500
--
Pretax Income
-11,200.9230
-11,803.7740
-14,414.2660
-31,694.0480
-3,868.6500
--
Tax Provision
--
-99.7840
--
--
--
--
Net Income Common Stockholders
-11,101.1390
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
--
Diluted NI Available to Com Stockholders
-11,101.1390
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
--
Basic EPS
-0.12
-0.12
-0.14
-0.34
-0.05
--
Diluted EPS
-0.12
-0.12
-0.14
-0.34
-0.05
--
Basic Average Shares
100,837.7200
100,503.4420
99,436.2640
92,091.9830
84,022.4240
--
Diluted Average Shares
100,837.7200
100,503.4420
99,436.2640
92,091.9830
84,022.4240
--
Total Operating Income as Reported
--
--
--
-12,562.6650
-4,313.7200
-1,677.8750
Rent Expense Supplemental
310.3940
359.6510
362.3710
196.9940
51.5700
--
Total Expenses
11,296.9750
12,008.3340
14,725.8000
12,324.6410
3,978.4470
--
Net Income from Continuing & Discontinued Operation
-11,101.1390
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
--
Normalized Income
-10,944.6080
-11,548.7822
-14,270.1600
-12,022.1130
-3,868.6500
--
Interest Income
302.6940
405.4830
510.2570
20.5970
4.1070
--
Interest Expense
109.0100
107.3730
120.6240
63.7770
6.4600
--
Net Interest Income
189.1050
293.4120
384.8000
-46.5390
-2.3530
--
EBIT
-11,091.9130
-11,696.4010
-14,293.6420
-31,630.2710
-3,862.1900
--
EBITDA
-10,465.1510
-11,082.6870
-13,753.9490
-31,015.5610
-3,735.3910
--
Reconciled Cost of Revenue
356.4480
331.0800
853.3360
376.7870
126.7990
--
Reconciled Depreciation
626.7620
613.7140
539.6930
614.7100
126.7990
--
Net Income from Continuing Operation Net Minority Interest
-11,101.1390
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
--
Total Unusual Items Excluding Goodwill
-156.5310
-156.5310
-144.1060
-19,671.9350
--
--
Total Unusual Items
-156.5310
-156.5310
-144.1060
-19,671.9350
--
--
Normalized EBITDA
-10,308.6200
-10,926.1560
-13,609.8430
-11,343.6260
-3,735.3910
--
Tax Rate for Calcs
--
0.0000
--
--
--
--
Tax Effect of Unusual Items
--
-1.3232
--
--
--
--
3/31/2020 - 4/2/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
S2M.ST S2Medical AB (publ)
0.0155
-8.82%
0094.KL Zen Tech International Berhad
0.0100
0.00%
ISRG.NE Intuitive Surgical, Inc.
27.76
-0.22%
RSCF Reflect Scientific, Inc.
0.0500
+1.01%
MBOT Microbot Medical Inc.
0.9768
+1.73%
MHUA Meihua International Medical Technologies Co., Ltd.
0.6752
-1.07%
STXS Stereotaxis, Inc.
1.8900
-1.05%
POAI Predictive Oncology Inc.
0.8360
+17.20%
LUCY Innovative Eyewear, Inc.
5.84
-4.73%
BNGO Bionano Genomics, Inc.
0.3058
+3.45%